Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
On Aug. 28, AMCP responded to Senate HELP Chairman Bill Cassidy's 340B reform proposal.
AMCP supports efforts to make prescription medications more affordable for Medicare beneficiaries. At the same time, implementation of the Medicare Drug Price Negotiation Program (Negotiation Program) should preserve the evidence-based formulary management, utilization management, market competition, and clinical decision-making processes fundamental to managed care pharmacy.
The No Surprises Act Enforcement Act would increase insurer penalties up to $10,000 per surprise billing violation.
On June 16, Senate Finance Committee Democrats released an RFI on proposals to lower the cost of prescription drugs. On Aug. 17, AMCP submitted comments in response.
On June 5, the New York State Assembly passed S.5939C/A.5882C, commonly referred to as the Patient Access to Pharmacy Act (PAPA), sending the pharmacy benefit manager (PBM) reimbursement legislation to Governor Kathy Hochul for consideration. The Senate previously passed the measure on May 28.
On August 11, 2026, the Centers for Medicare and Medicaid Services issues a final rule titled, “Prohibition on Federal Medicaid and Children’s Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children” (Final Rule).
The Final Rule prohibits payments to State Medicaid plans for “sex-rejecting procedures” for children under 18 or to a separate Children’s Health Insurance Program (CHIP) for children under 19. Among the definitions included in the Final Rule are:
AMCP and Omnicom Health Market Access, are pleased to announce that three Precision Medicine-related articles, co-authored by AMCP and Omnicom Health Market Access team members, have been accepted for publication in the Journal of Managed Care & Specialty Pharmacy (JMCP). The articles represent a significant contribution to advancing standardization in how precision medicine is managed across the market access landscape.
On August 10, 2026, President Trump signed an Executive Order titled, Delivering Gold Standard Childhood Vaccine Recommendations for Americans (the EO). The EO recommends all children get immunizations for 11 diseases, a decrease from the 18 diseases recommended by the Centers for Disease Control and Prevention in 2024. The EO states that immunizations that are no longer recommended for all children are now recommended for shared clinical decision-making.
